Permian Resources Corporation Class A Common Stock vs uniQure N.V. Ordinary Shares — how do they compare? Permian Resources Corporation Class A Common Stock trades at $23.59 (market cap $20.15B), while uniQure N.V. Ordinary Shares trades at $21.79 (market cap $1.45B). The key difference: Permian Resources Corporation Class A Common Stock is far larger — about 13.9× uniQure N.V. Ordinary Shares's market cap, and Permian Resources Corporation Class A Common Stock pays a 2.62% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Permian Resources Corporation Class A Common Stock for 5 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PR | QURE | |
|---|---|---|
Market Cap | $20.15B | $1.45B |
Volume | 10,820,061 | 3,323,243 |
Sector | Energy | Health |
52-Week High | $24.49 | $70.59 |
52-Week Low | $12.09 | $9.03 |
Typical Hold Time | 5 Days | 0 Days |
Enterprise Value | $23.15B | $707.46M |
Dividend Yield | 2.62% | — |
Signals from Pluang's Aura AI — not financial advice
Permian Resources (PR) trades at $24.26, up 3.68% on the day and near its 52-week high, with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with $5.07B revenue, 21.52% net income margin, and attractive valuation metrics including a P/E of 15.65 and EV/EBITDA of 5.83. Recent earnings show mixed results with Q2 2026 beating expectations by 59% while Q1 2026 missed estimates.
The outlook remains positive with 90% analyst buy ratings and $27.00 consensus price target representing 11% upside. Key opportunities include disciplined acquisition strategy and raised 2026 guidance, while risks involve oil price volatility and execution of capital spending plans. The stock offers growth potential but requires monitoring of quarterly execution consistency.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Permian Resources explores for and produces oil and natural gas in the Permian Basin. Its operations are concentrated in the Delaware Basin of West Texas and New Mexico.
Read more on PR →uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →